Cannabinoid agonist HU-210 reduced sucrose consumption in rats through CB1 receptor-mediated motor impairment
The cannabinoid agonist HU-210 paradoxically reduced sucrose intake in rats by impairing the motor mechanics of licking rather than reducing reward value, an effect blocked by rimonabant.
Quick Facts
What This Study Found
HU-210 reduced licking by decreasing burst number and intra-burst lick rate (a motor competence index). These effects were antagonized by rimonabant (CB1 antagonist), confirming CB1 dependence. Rimonabant at 0.5 mg/kg decreased burst number late in sessions, resembling reward devaluation, suggesting it reduced "liking."
Key Numbers
HU-210: 25, 50, 100 ug/kg. Rimonabant: 0.5, 1 mg/kg. HU-210 reduced both burst number and intra-burst lick rate. Rimonabant at 0.5 mg/kg reduced burst number late in session.
How They Did This
Two experiments analyzing the microstructure of licking for 10% sucrose in 30-minute sessions. Experiment 1 tested rimonabant-HU-210 interactions; Experiment 2 tested a dose range of HU-210. Licking burst patterns analyzed for reward and motor components.
Why This Research Matters
Understanding how cannabinoids affect feeding behavior at the microstructural level helps separate reward effects from motor effects, which has implications for understanding both appetite regulation and cannabinoid side effects.
The Bigger Picture
The finding that some cannabinoid agonists can reduce rather than increase feeding challenges simple narratives about cannabis and appetite, highlighting the importance of receptor pharmacology.
What This Study Doesn't Tell Us
Animal model using synthetic agonists; sucrose licking is a simplified model of feeding behavior; HU-210 is pharmacologically distinct from THC.
Questions This Raises
- ?Would THC show similar motor impairment effects at high doses?
- ?Does the late-session rimonabant effect represent genuine reward devaluation?
Trust & Context
- Key Stat:
- HU-210 impaired motor mechanics of licking; rimonabant reduced apparent reward value
- Evidence Grade:
- Single animal study with detailed behavioral microstructure analysis but using synthetic agonists.
- Study Age:
- Published in 2020.
- Original Title:
- Microstructure analysis of the effects of the cannabinoid agents HU-210 and rimonabant in rats licking for sucrose.
- Published In:
- European journal of pharmacology, 887, 173468 (2020)
- Authors:
- D'Aquila, Paolo S
- Database ID:
- RTHC-02488
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Don't cannabinoids usually increase appetite?
Generally yes, but the effects depend on the specific compound and dose. HU-210 is a potent non-selective cannabinoid agonist that, paradoxically, can reduce feeding. This study found the reduction was due to motor impairment rather than decreased reward value.
What does this tell us about rimonabant and weight loss?
Rimonabant (a CB1 antagonist previously used for weight loss before being withdrawn) appeared to reduce the reward value of sucrose when analyzed at the microstructural level, which could explain its appetite-suppressing effects.
Read More on RethinkTHC
- cannabis-cardiovascular-heart-risk-stroke
- cannabis-heart-cardiovascular-risk
- coughing-up-stuff-after-quitting-weed
- lung-recovery-after-quitting-smoking-weed
- lung-recovery-quitting-weed
- quitting-weed-female-hormones
- quitting-weed-weight-gain-loss-diet-appetite
- sex-after-quitting-weed
- weed-DUI-driving-impaired-cannabis-laws
- weed-acne-skin
- weed-fertility-sperm
- weed-gut-digestion-problems
- weed-heart-health
- weed-testosterone-levels
Cite This Study
https://rethinkthc.com/research/RTHC-02488APA
D'Aquila, Paolo S. (2020). Microstructure analysis of the effects of the cannabinoid agents HU-210 and rimonabant in rats licking for sucrose.. European journal of pharmacology, 887, 173468. https://doi.org/10.1016/j.ejphar.2020.173468
MLA
D'Aquila, Paolo S. "Microstructure analysis of the effects of the cannabinoid agents HU-210 and rimonabant in rats licking for sucrose.." European journal of pharmacology, 2020. https://doi.org/10.1016/j.ejphar.2020.173468
RethinkTHC
RethinkTHC Research Database. "Microstructure analysis of the effects of the cannabinoid ag..." RTHC-02488. Retrieved from https://rethinkthc.com/research/d-aquila-2020-microstructure-analysis-of-the
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.